Impact of a Multidisciplinary Assessment in Day Hospitalization Versus Standard Care on the Deployment of Supportive Oncology Care Recommended by the Personalized Post-cancer Plan in Patients at the End of Initial Treatment for Gynecological Ovarian and Endometrial Cancer Endometrial Cancer
- Gynecologic Cancer
- Remission
At a glance
- Phase
- Phase not stated
- Study type
- Interventional
- Sponsor
- Centre Francois Baclesse
- Enrolment target
- 268
- Started
- 7 June 2024
- Main results due
- 7 September 2028
- Study sites
- 13
- Registry updated
- 24 September 2026
Can you take part?
- Aged 18 years and over.
- Women only.
- You need the condition being studied — healthy volunteers are not accepted.
These are the headline rules only. Every study has a longer list, and whether you are eligible is decided by the research team at the site — never by this page.
Read the full eligibility criteria
Inclusion Criteria: * Patient \> 18 years * Patients in remission from first-line treatment of endometrial or ovarian/tumor/peritoneal cancer. * Patient who has completed her initial treatment; patients on maintenance therapy are eligible. * Fluency in French * Patient with access to a telephone line * Patient affiliated to a social security scheme * Signature of informed consent prior to any specific study procedure Exclusion Criteria: * Any associated medical or psychiatric condition that could compromise the patient's ability to participate in the study * Patient with locoregional or metastatic recurrence * Patient deprived of liberty, under guardianship or curatorship * Simultaneous participation in a therapeutic clinical trial
What this study is about
In the sponsor’s own words, from the registry.
This project proposes a structuring of supportive oncology care for the recovery phase after gynecological cancer (ovarian/trope/peritoneum or endometrium). Patients will be divided into three groups based on the identification of oncological support care needs. Patients with supportive oncology care needs will be randomized into two groups: the experimental group, receiving a personalized post-cancer plan with a multidisciplinary assessment of supportive oncology care needs in a day hospital and coordinated follow-up by the referring study nurse, and the control group, receiving a personalized post-cancer plan without a day hospital. Randomization will be stratified according to tumor location (ovary vs. endometrium), use of supportive oncology care during treatment, and treatment center. Patients with no need for supportive oncology care will be followed in an observational cohort. The main objective is to identify and manage the supportive oncology care needs of patients in remission from endometrial or ovarian cancer to improve their quality of life and post-treatment follow-up. A medico-economic analysis will be performed.
Study sites(13)
CHU, Besançon
Besançon, France
Recruiting
François Baclesse
Caen, France
Recruiting
Centre Jean Perrin
Clermont-Ferrand, France
Not yet recruiting
Centre Léon Bérard
Lyon, France
Recruiting
Hopital Diaconesses Croix Saint-Simon
Paris, France
Recruiting
Hopital Europeen George Pompidou
Paris, France
Not yet recruiting
Hôpital COCHIN
Paris, France
Not yet recruiting
Institut Curie
Paris, France
Not yet recruiting
Hopital privé des Côtes d'Armor
Plérin, France
Not yet recruiting
Institut Curie, St Cloud
Saint-Cloud, France
Recruiting
CHU, Saint Etienne
Saint-Etienne, France
Not yet recruiting
CHU
Strasbourg, France
Recruiting
Gustave Roussy
Villejuif, France
Recruiting
Showing 13 of 13 sites. 7 of the 13 sites on this study are recruiting right now — a site can stop enrolling while the study as a whole is still open.
Source: ClinicalTrials.gov record NCT06553612. Trialion does not run this study, is not paid to refer anyone to it, and cannot enrol you. Eligibility is always decided by the research team at the site.
Not the right study?
Answer three questions and see the studies recruiting near you, in plain language.
Find a study for me